Font Size: a A A
Keyword [scleroderma]
Result: 81 - 100 | Page: 5 of 6
81. Study On The Vascular Mechanism Of Treating The Scleroderma By Dangguisini Decoction On AECA,vWF,TXB2,6-keto-PGF1? From Scleroderma Model Mice
82. The Expression And Significance Of Cthrcl And TGF-?1/smad Signaling Pathway In Scleroderma Fibroblasts
83. Multiphoton Microscopic Imaging Of Sclerosing Atrophic And Scleroderma
84. A Preliminary Study On The Role Of SIRT1 In Insulin Resistance Of Scleroderma Mice
85. The Research On The Mechanisms Of Preventive Effect On The SSc By Using The Formula Of Bufei Qingyu Under The Method Of Xuanfu
86. The Role And Mechanism Of IL-33/ST2 In Skin Fibrosis Of Systemic Sclerosis
87. Effects Of Safflower Decoction On Skin And Lung Fibrosis And The Expression Of TGF-?1 And IL-10 In Scleroderma Mice
88. The Expression Of LIGHT And Its Receptors In Scleroderma,keloid And Lichen Sclerosus Et Atrophicus
89. Professor Guo Gang's Clinical Experience And Medication Rules In The Treatment Of Local Scleroderma Research
90. Efficacy Of Mycophenolate Mofetil For The Treatment Of Systemic Sclerosis Related Interstitial Lung Disease:A Meta-Analysis
91. Bioinformatics Analysis And Functional Studies Of Hsa-miR-26b-5p In Scleroderma
92. Study On Ultrasonic Extraction And Optimization Of Liquid Fermentation Process And Antibacterial Activity Research Of Puffball Polysaccharide
93. Clinical Observation On The Treatment Of Localized Scleroderma(Arthromyodynia Of Wind-Damp) By Fumigation And Washing Of Traditional Chinese Medicine(ErWu-Jian)
94. The Mechanism Of Protein Kinase D2 Contributions To The Bleomycin-induced Localized Scleroderma In Mice
95. A Retrospective Case-control Study On The Relationship Between Autoantibody Anti-Scl-70 And Clinical Features Of Systemic Sclerosis
96. Therapeutic Effect Of Adipose Tissue-derived Stem Cells On Bleomycin-induced Mice Of Scleroderma
97. The Effect Of Thalidomide On Inflammation And Fibrosis In Mice With Systemic Sclerosis
98. TGF-beta/Smad1 signaling defines a subset of scleroderma fibroblasts
99. Immunogenetic and environmental risk factors for scleroderma and lupus
100. Novel predictors of clinical expression in scleroderma
  <<First  <Prev  Next>  Last>>  Jump to